September 28, 2012. The ASTM standard that claims some bumper pads are less risky will muddle the safety issue even more and give parents a false sense of security. Maryland’s proposed ban on crib bumper pads will help to protect more than 70,000 babies born in the state each year, and that is a bottom line upon which we should all agree.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
Letter to Representative Markey in Support of Legislation That Would Give the FDA Authority to Oversee Compounding Pharmacies
October 21, 2012. This letter expresses support for Massachusetts Representative Ed Markey’s proposed legislation that would give the FDA more authority over compounding pharmacies.
Read More »NCHR Statement on Compounding Pharmacies: Loopholes That Kill
October 31, 2012. We call on Congress to work in a bipartisan manner to pass legislation necessary to protect our families from these predictable, preventable tragedies.
Read More »Statement of NCHR On Behalf of Members of the Patient, Consumer and Public Health Coalition on Bumper Pads
October 2012. Members of our coalition of nonprofit organizations strongly oppose the use of ASTM International Standard (F1917-12) as a safety standard for baby bumper pads. Instead, Maryland’s proposed ban on crib bumper pads will help to protect more than 70,000 babies born in the state each year, and that is a bottom line upon which we should all agree.
Read More »Comments on Requirement for Premarket Approval for Shortwave Diathermy for All Other Uses
October 4, 2012. Members of the Patient, Consumer, and Public Health Coalition strongly support the FDA’s proposed rule to require Premarket Approval Application (PMA) for the Class III preamendments device Shortwave Diathermy (SWD) for all other uses except for the treatment of malignancies. However, we oppose FDA’s proposal to allow a Product Development Protocol (PDP) instead of a PMA for this device because PDPs are for devices where a sponsor comes to an “early agreement with FDA as to what would be done to demonstrate the safety and effectiveness of a new device.”
Read More »